Nir Debotton
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- Advanced Drug Delivery Systems 3
- Drug Solubulity and Delivery Systems 2
- Advancements in Transdermal Drug Delivery 2
-
- Advanced biosensing and bioanalysis techniques 2
- RNA Interference and Gene Delivery 1
- Co-authors
- Simon Benita (5 shared papers)Oshrat Harush-Frenkel (2 shared papers)Yoram Altschuler (1 shared paper)Arik Dahan (5 shared papers)Jean Kadouche (2 shared papers)Hagit Zer (1 shared paper)Yoram Soroka (1 shared paper)Marina Frušić‐Zlotkin (1 shared paper)
- Journals
- International Journal of Pharmaceutics (2 papers)Journal of Controlled Release (2 papers)Drug Design Development and Therapy (1 paper)Biochemical and Biophysical Research Communications (1 paper)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)
- Partner nations
- Israel
In The Last Decade
Nir Debotton
10 papers receiving 672 citations
Peers
Comparison fields: 5 of 98
- Biomaterials 279
- Pharmaceutical Science 127
- Surfaces, Coatings and Films 37
- Molecular Medicine 23
- Biomedical Engineering 159
Countries citing papers authored by Nir Debotton
This map shows the geographic impact of Nir Debotton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nir Debotton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nir Debotton more than expected).
Fields of papers citing papers by Nir Debotton
This network shows the impact of papers produced by Nir Debotton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nir Debotton. The network helps show where Nir Debotton may publish in the future.
Co-authors
The 14 scholars most cited alongside Nir Debotton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 490 | |
| 2 | 2016 | 97 | |
| 3 | 2008 | 30 | |
| 4 | 2009 | 21 | |
| 5 | 2014 | 13 | |
| 6 | 2014 | 12 | |
| 7 | 2022 | 10 | |
| 8 | 2018 | 5 | |
| 9 | 2017 | 5 | |
| 10 | 2023 | 4 |
About Nir Debotton
Nir Debotton is a scholar working on Pharmaceutical Science, Molecular Biology, Dermatology, Pediatrics, Perinatology and Child Health and Oncology, having authored 10 papers that have together received 687 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (3 papers), Contact Dermatitis and Allergies (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Drug Solubulity and Delivery Systems (2 papers), Advancements in Transdermal Drug Delivery (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Pharmaceutical studies and practices (2 papers) and RNA Interference and Gene Delivery (1 paper). The work is most often cited by research in Biomaterials (279 citations), Pharmaceutical Science (127 citations), Surfaces, Coatings and Films (37 citations), Molecular Medicine (23 citations) and Biomedical Engineering (159 citations). Nir Debotton has collaborated with scholars based in Israel. Frequent co-authors include Simon Benita, Oshrat Harush-Frenkel, Yoram Altschuler, Arik Dahan, Jean Kadouche, Hagit Zer, Yoram Soroka, Marina Frušić‐Zlotkin, Gershon Holcberg and Hana Polachek. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Controlled Release, Drug Design Development and Therapy, Biochemical and Biophysical Research Communications and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.